advertisement

---

Grehn F 2

Showing records 1 to 2 | Display all abstracts from Grehn F

20043 A phase III study of subconjunctival human anti-transforming growth factor β² monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy
CAT-152 0102 Trabeculectomy Study Group; Khaw P; Grehn F; Holló G; Overton B; Wilson R; Vogel R; Smith Z
Ophthalmology 2007; 114: 1822-1830

---

20042 Factors affecting the outcome of trabeculectomy: an analysis based on combined data from two phase III studies of an antibody to transforming growth factor β², CAT-152
CAT-152 Trabeculectomy Study Group; Grehn F; Holló G; Khaw P; Overton B; au; Wilson R; Vogel R; Smith Z
Ophthalmology 2007; 114: 1831-1838

---